Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1246 of 5804
-
Immune cell combo targets stubborn leukemia in early trial
Disease control Recruiting nowThe researchers are doing this study is to find the highest dose of cytokine-induced memory-like (CIML) natural killer (NK) cells in combination with the drug atezolizumab that causes few or mild side effects in people with relapsed/refractory acute myelogenous leukemia (AML). Th…
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo therapy targets rare, aggressive kidney tumors
Disease control Recruiting nowThis is a single-arm, monocentric, phase II trial, enrolling patients with histological diagnosis of collecting duct carcinoma and renal medullary carcinoma with locally advanced or metastatic disease who will be treated with Pembrolizumab plus Enfortumab Vedotin. Approximately,…
Phase: PHASE2 • Sponsor: Giuseppe Procopio • Aim: Disease control
Last updated Jun 26, 2026 15:17 UTC
-
New pill hopes to shrink painful nerve tumors in NF1 patients
Disease control Recruiting nowThe main purpose of this clinical trial is to test PAS-004 in people with at least one symptomatic plexiform neurofibroma due to Neurofibromatosis Type 1 (NF1). The main questions it aims to answer are: * How well participants are able tolerate different doses of PAS-004, and * …
Phase: PHASE1 • Sponsor: Pasithea Therapeutics Corp. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
AI could spot hidden lung danger in scleroderma patients
Knowledge-focused Recruiting nowPulmonary Arterial Hypertension (PAH) is a rare and severe condition that can be associated with Systemic Sclerosis (SSc), significantly worsening the prognosis of the latter disease. Screening programs based on clinical, laboratory, pulmonary function test, electrocardiographic,…
Sponsor: Alejandro Cruz Utrilla • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
New monthly shot could tame rare kidney disease
Disease control OngoingThis is a Phase 2, open-label, multicenter, randomized study comprising parallel groups of participants receiving weekly and/or monthly doses of atacicept
Phase: PHASE2 • Sponsor: Vera Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New pill targets KRAS mutations in Hard-to-Treat cancers
Disease control Recruiting nowThis study is to evaluate the safety and tolerability of pan-KRAS inhibitor JAB-23E73 in adult participants with advanced solid tumors
Phase: PHASE1, PHASE2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Can a simple blood test predict which pancreatic cysts turn cancerous?
Knowledge-focused Recruiting nowIntraductal papillary mucinous neoplasms (IPMN) are one of the main precursor lesions of pancreatic ductal adenocarcinoma (PDAC), a lethal disease predicted to become the second leading cause of cancer-related deaths in Western societies within a decade. The mechanisms underlying…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:08 UTC
-
New study tests two procedures for chronic migraine relief
Disease control OngoingThe study included 100 patients diagnosed with chronic migraine (CM) who received a diagnosis from the headache clinics of the Neurology Department of Adnan Menderes University Hospitals between May 2025 and May 2026. Inclusion criteria were patients over 18 years of age with chr…
Phase: NA • Sponsor: Aydin Adnan Menderes University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New biocomposite aims to mend broken bones better than standard care
Disease control Recruiting nowThe aim of this clinical study is to evaluate the efficacy, safety and long-term (radiological and clinical) outcomes during comprehensive care continuum of implanted biocomposite for bone regeneration FlexiOss® compared to the current standard of care in patients with primary ac…
Phase: NA • Sponsor: Medical Inventi S.A. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New experimental drug HS-20108 enters human trials for advanced cancers
Disease control Recruiting nowThis is a Phase I clinical study of HS-20108. The purpose of this study is to evaluate the safety, tolerability, PK and efficacy of intravenous HS-20108 in patients with advanced solid tumors.
Phase: PHASE1 • Sponsor: Hansoh BioMedical R&D Company • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New PET scan could reveal which breast cancer patients respond to immunotherapy
Knowledge-focused Recruiting nowThis study plans to enroll 30 patients with locally advanced or metastatic triple-negative breast cancer (TNBC) who are scheduled to receive at least two cycles of a regimen containing an immune checkpoint inhibitor (ICI). All ICI treatments must be administered in accordance wit…
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
New pill could tame stubborn hives that antihistamines Can't stop
Disease control OngoingThis is a 2-part, proof-of-concept study to be conducted globally, designed to evaluate the safety, tolerability, clinical activity, pharmacokinetics, and pharmacodynamics of BLU-808, a wild type KIT inhibitor, in participants with CIndU (Part A) or CSU (Part B).
Phase: PHASE2 • Sponsor: Blueprint Medicines Corporation • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New device aims to wean ventilator patients faster
Disease control Recruiting nowMulti-center, randomized, controlled, open-label Phase 2 feasibility trial. Subjects on mechanical ventilation (MV) for acute hypoxemic respiratory failure (AHRF) with lung injury (including subjects who meet criteria for acute respiratory distress syndrome (ARDS)) will be random…
Phase: NA • Sponsor: Lungpacer Medical Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New pill shows promise for Long-Term IBD control
Disease control Recruiting nowCrohn's Disease and Ulcerative Colitis are two types of inflammatory bowel disease (IBD), which is a serious, long-term condition in the gut (intestine) that can cause pain and swelling (inflammation) in the bowel. TAK-279 is a medicine which helps to block inflammation. This st…
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Four-in-One imaging may predict breast cancer treatment success
Knowledge-focused Recruiting nowThe aim of our study is to find the best imaging technique, alone or in combination, that can best predict a complete response (absence of tumour cells). It also seems important to identify blood markers able to predict which patients will benefit most from treatment, with a view…
Phase: NA • Sponsor: Centre Henri Becquerel • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Spinal stimulation at home could restore arm movement after injury
Symptom relief Recruiting nowThe purpose of this research is to evaluate the safety, feasibility, and tolerability of non-invasive spinal stimulation used in the home and/or community in combination with a functional home exercise program for the upper extremities (arm/hand function) as well as their combine…
Phase: NA • Sponsor: Craig Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Can cannabis calm anxiety in autism? new trial aims to find out
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if drug ABC works to treat severe asthma in adults. It will also learn about the safety of drug ABC. The main questions it aims to answer are: Will a marijuana-based drug help anxiety in autistic adults? Anxiety can make socializing a…
Phase: PHASE2 • Sponsor: Southwest Autism Research & Resource Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Magic mushroom compound scanned in depression trial
Knowledge-focused Recruiting nowThe goal of this neuroimaging clinical trial is to test whether psilocybin produces significant immediate changes in functional brain activity in networks associated with mood regulation and depression compared to placebo in patients with depression. The trial aims to determine i…
Phase: PHASE2 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Time-Restricted eating tested to cut heart risk in childhood cancer survivors
Disease control Recruiting nowThis study will look at whether motivational sessions (including regular calls with a trained health coach) in combination with time-restricted eating (TRE) is an effective way to achieve weight loss and lower cardiometabolic risk in adult survivors of childhood cancer. The resea…
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Magic mushroom therapy could ease persistent concussion symptoms
Symptom relief Recruiting nowThe goal of this randomized controlled trial is to evaluate the safety, feasibility, and efficacy of psilocybin assisted therapy as an intervention to reduce symptom burden in adult patients (aged 18-65) with persisting symptoms after concussion (PSaC). This trail will test the …
Phase: PHASE1 • Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC